Recombinant Human NABP1 Protein, N-His-SUMO

Description of Recombinant Human NABP1 Protein, N-His-SUMO

Recombinant Human NABP1 Protein, also known as Nucleic Acid Binding Protein 1, is a highly conserved protein that plays a crucial role in DNA replication and repair. This protein is encoded by the NABP1 gene and is expressed in various tissues, including the brain, heart, and liver. Recombinant Human NABP1 Protein is commonly used in research and diagnostic applications due to its unique structure and function.

Recombinant Human NABP1 Protein is composed of 482 amino acids and has a molecular weight of approximately 54 kDa. It is a homodimer, meaning it is made up of two identical subunits, with each subunit containing three distinct domains. The N-terminal domain is responsible for DNA binding, the central domain is involved in protein-protein interactions, and the C-terminal domain is responsible for dimerization. The structure of Recombinant Human NABP1 Protein is essential for its function in DNA binding and repair.

Recombinant Human NABP1 Protein is a key player in maintaining genome stability by binding to damaged DNA and recruiting other proteins involved in DNA repair. It has a high affinity for single-stranded DNA and can also bind to double-stranded DNA. This protein is involved in various DNA repair pathways, including base excision repair, nucleotide excision repair, and mismatch repair. Additionally, Recombinant Human NABP1 Protein has been shown to regulate cell cycle progression and apoptosis, further highlighting its essential role in maintaining genomic integrity.

Recombinant Human NABP1 Protein has numerous applications in both research and diagnostic settings. Its ability to bind to damaged DNA makes it a valuable tool for studying DNA repair mechanisms and the role of this protein in maintaining genome stability. This protein has also been implicated in various diseases, including cancer, making it a potential therapeutic target.

In diagnostic applications, Recombinant Human NABP1 Protein is used as an antigen in immunoassays for the detection of autoantibodies. Autoantibodies against this protein have been found in patients with autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. By using Recombinant Human NABP1 Protein as an antigen, these autoantibodies can be detected and used as biomarkers for disease diagnosis and monitoring.

Furthermore, Recombinant Human NABP1 Protein has been shown to have potential as a prognostic marker in various cancers. Studies have found that higher levels of this protein are associated with a better prognosis in breast cancer patients, while lower levels are associated with a poorer prognosis in patients with non-small cell lung cancer. This highlights the potential of Recombinant Human NABP1 Protein as a biomarker for cancer prognosis and personalized treatment strategies.

In summary, Recombinant Human NABP1 Protein is a crucial protein involved in DNA repair and maintenance of genomic stability. Its unique structure and function make it a valuable tool in research and diagnostic applications. With its potential as a therapeutic target and biomarker for various diseases, this protein continues to be a subject of interest for scientists and clinicians alike.